AAAAAA

   
Results: 1-7 |
Results: 7
A high prevalence of hypovitaminosis D in Finnish medical in- and outpatients
Authors: Kauppinen-Makelin, R Tahtela, R Loyttyniemi, E Karkkainen, J Valimaki, MJ
Citation: R. Kauppinen-makelin et al., A high prevalence of hypovitaminosis D in Finnish medical in- and outpatients, J INTERN M, 249(6), 2001, pp. 559-563
Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (calcitriol) for four years
Authors: Sairanen, S Karkkainen, M Tahtela, R Laitinen, K Makela, PP Lamberg-Allardt, C Valimaki, MJ
Citation: S. Sairanen et al., Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (calcitriol) for four years, CALCIF TIS, 67(2), 2000, pp. 122-127
A prospective study of bone loss and turnover after cardiac transplantation: Effect of calcium supplementation with or without calcitonin
Authors: Valimaki, MJ Kinnunen, K Tahtela, R Loyttyniemi, E Laitinen, K Makela, P Keto, P Nieminen, M
Citation: Mj. Valimaki et al., A prospective study of bone loss and turnover after cardiac transplantation: Effect of calcium supplementation with or without calcitonin, OSTEOPOR IN, 10(2), 1999, pp. 128-136
Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults
Authors: Valimaki, MJ Salmela, PI Salmi, J Viikari, J Kataja, M Turunen, H Soppi, E
Citation: Mj. Valimaki et al., Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults, EUR J ENDOC, 140(6), 1999, pp. 545-554
Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms
Authors: Wymenga, ANM Eriksson, B Salmela, PI Jacobsen, MB Van Cutsem, EJDG Fiasse, RH Valimaki, MJ Renstrup, J de Vries, EGE Oberg, KE
Citation: Anm. Wymenga et al., Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms, J CL ONCOL, 17(4), 1999, pp. 1111-1117
A prospective study of bone loss and turnover after allogeneic bone marrowtransplantation: effect of calcium supplementation with or without calcitonin
Authors: Valimaki, MJ Kinnunen, K Volin, L Tahtela, R Loyttyniemi, E Laitinen, K Makela, P Keto, P Ruutu, T
Citation: Mj. Valimaki et al., A prospective study of bone loss and turnover after allogeneic bone marrowtransplantation: effect of calcium supplementation with or without calcitonin, BONE MAR TR, 23(4), 1999, pp. 355-361
Ovarian hyperstimulation caused by gonadotroph adenoma secreting follicle-stimulating hormone 28-year-old woman
Authors: Valimaki, MJ Tiitinen, A Alfthan, H Paetau, A Poranen, A Sane, T Stenman, UH
Citation: Mj. Valimaki et al., Ovarian hyperstimulation caused by gonadotroph adenoma secreting follicle-stimulating hormone 28-year-old woman, J CLIN END, 84(11), 1999, pp. 4204-4208
Risultati: 1-7 |